A molecular characterization of the choroid plexus and stress-induced gene regulation

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Sathyanesan, M ^a   Girgenti, M J ^a   Banasr, M ^a   Stone, K ^a   Bruce, C ^a   Guilchicek, E ^a   Wilczak Havill, K ^a   Nairn, A ^a   Williams, K ^a   Sass, S ^b   Duman, J G ^b   Newton, S S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

choroid plexus; cilia; inflammation; microarray; proteome

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKERATIN; EZRIN; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1BETA; KLOTHO PROTEIN; ORGANIC ANION TRANSPORTER 1; RAB7 PROTEIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SMOOTHENED PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CORTEX; CHOROID PLEXUS; CHRONIC STRESS; CONTROLLED STUDY; EPENDYMA; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; MALE; MOOD DISORDER; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEOMICS; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TISSUE CHARACTERIZATION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

ANIMALS; CEREBRAL CORTEX; CHOROID PLEXUS; DEPRESSION; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; MALE; MASS SPECTROMETRY; PROTEIN ARRAY ANALYSIS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL;

EID: 84863750746     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.64     Document Type: Article

References (67)

1. Johanson CE. The Choroid Plexus-CSF Nexus, Gateway to the brain. In: Conn MP (ed). Neuroscience in Medicine. Humana Press Inc: Totowa, NJ, 2003, pp 165-195.
2. Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I. J Neurosci 2005; 25: 10884-10893. (Pubitemid 41692618)
3. Richardson SJ. Cell and molecular biology of transthyretin and thyroid hormones. Int Rev Cytol 2007; 258: 137-193. (Pubitemid 46330485)
4. Crossgrove JS, Li GJ, Zheng W. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Exp Biol Med (Maywood, NJ) 2005; 230: 771-776. (Pubitemid 41565947)
5. Spector R, Johanson C. Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res 2006; 23: 2515-2524. (Pubitemid 44691598)
6. Spector R, Johanson CE. Vitamin transport and homeostasis in mammalian brain: focus on vitamins B and E. J Neurochem 2007; 103: 425-438. (Pubitemid 47498022)
7. Chodobski A, Szmydynger-Chodobska J. Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech 2001; 52: 65-82. (Pubitemid 32065030)
8. Skipor J, Thiery JC. The choroid plexus - cerebrospinal fluid system: undervaluated pathway of neuroendocrine signaling into the brain. 2008; 68: 414-428.
9. Johanson CE, Duncan JA, Stopa EG, Baird A. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm Res 2005; 22: 1011-1037. (Pubitemid 41130789)
10. Banizs B, Pike MM, Millican CL, Ferguson WB, Komlosi P, Sheetz J et al. Dysfunctional cilia lead to altered ependyma and choroid plexus function, and result in the formation of hydrocephalus. Development (Cambridge, England) 2005; 132: 5329-5339. (Pubitemid 43020186)
11. Mitchell K, Yang HY, Berk JD, Tran JH, Iadarola MJ. Monocyte chemoattractant protein-1 in the choroid plexus: a potential link between vascular pro-inflammatory mediators and the CNS during peripheral tissue inflammation. Neuroscience 2009; 158: 885-895.
12. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009; 10: 514-523.
13. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 2003; 23: 10841-10851. (Pubitemid 37499691)
14. Laakso A, Palvimaki EP, Kuoppamaki M, Syvalahti E, Hietala J. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus. Neuropsychopharmacology 1996; 15: 143-151. (Pubitemid 26255161)
15. Serot JM, Bene MC, Foliguet B, Faure GC. Morphological alterations of the choroid plexus in late-onset Alzheimer's disease. Acta Neuropathologica 2000; 99: 105-108. (Pubitemid 30093415)
16. Serot JM, Foliguet B, Bene MC, Faure GC. Choroid plexus and ageing in rats: a morphometric and ultrastructural study. Eur J Neurosci 2001; 14: 794-798.
17. Barker EL, Sanders-Bush E. 5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol Pharmacol 1993; 44: 725-730.
18. Esterle TM, Sanders-Bush E. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. J Neurosci 1992; 12: 4775-4782.
19. Sanders-Bush E, Breeding M. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs. Psychopharmacology 1991; 105: 340-346.
20. Marques F, Sousa JC, Coppola G, Geschwind DH, Sousa N, Palha JA et al. The choroid plexus response to a repeated peripheral inflammatory stimulus. BMC Neuroscience 2009; 10: 135.
21. Marques F, Sousa JC, Coppola G, Gao F, Puga R, Brentani H et al. Transcriptome signature of the adult mouse choroid plexus. Fluids Barriers CNS 2011; 8: 10.
22. Kendler KS, Karkowski LM, Prescott CA. Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J Nerv Ment Dis 1998; 186: 661-669. (Pubitemid 29103863)
23. Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999; 156: 837-841. (Pubitemid 29260336)
24. Willner P. Chronic mild stress (CMS) revisited: consistency and behaviouralneurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90-110. (Pubitemid 41160326)
25. Banasr M, Valentine GW, Li XY, Gourley SL, Taylor JR, Duman RS. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 2007; 62: 496-504. (Pubitemid 47284039)
26. Ploski JE, Newton SS, Duman RS. Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J Neurochem 2006; 99: 1122-1132. (Pubitemid 44655278)
27. Hunsberger JG, Newton SS, Bennett AH, Duman CH, Russell DS, Salton SR et al. Antidepressant actions of the exercise-regulated gene VGF. Nat Med 2007; 13: 1476-1482. (Pubitemid 350224242)
28. Girgenti MJ, Collier E, Sathyanesan M, Su XW, Newton SS. Characterization of electroconvulsive seizure-induced TIMP-1 and MMP-9 in hippocampal vasculature. Int J Neuropsychopharmacol 2011; 14: 535-544.
29. Newton SS, Dow A, Terwilliger R, Duman R. A simplified method for combined immunohistochemistry and in-situ hybridization in fresh-frozen, cryocut mouse brain sections. Brain Res Brain Res Protoc 2002; 9: 214-219. (Pubitemid 34756724)
30. Marques F, Sousa JC, Coppola G, Gao F, Puga R, Brentani H et al. Transcriptome signature of the adult mouse choroid plexus. Fluids Barriers CNS 2010; 8: 10.
31. Zapala MA, Hovatta I, Ellison JA, Wodicka L, Del Rio JA, Tennant R et al. Adult mouse brain gene expression patterns bear an embryologic imprint. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 10357-10362. (Pubitemid 41023375)
32. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA 2007; 298: 1685-1687. (Pubitemid 47606658)
33. Spector R, Johanson CE. The mammalian choroid plexus. Sci Am 1989; 261: 68-74.
34. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51. (Pubitemid 27494749)
35. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P et al. Suppression of aging in mice by the hormone Klotho. Science (New York, NY) 2005; 309: 1829-1833. (Pubitemid 41325087)
36. Fisone G, Snyder GL, Aperia A, Greengard P. Na+,K(+)-ATPase phosphorylation in the choroid plexus: synergistic regulation by serotonin/protein kinase C and isoproterenol/cAMP-PK/PP-1 pathways. Mol Med (Cambridge, Mass) 1998; 4: 258-265. (Pubitemid 28331241)
37. Meister B, Fryckstedt J, Schalling M, Cortes R, Hokfelt T, Aperia A et al. Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 8068-8072. (Pubitemid 19265321)
38. Cornford EM, Varesi JB, Hyman S, Damian RT, Raleigh MJ. Mitochondrial content of choroid plexus epithelium. Exp Brain Res 1997; 116: 399-405. (Pubitemid 27448398)
39. Johanson CE, Duncan III JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008; 5: 10.
40. Maktabi MA, Heistad DD, Faraci FM. Effects of angiotensin II on blood flow to choroid plexus. Am J Physiol 1990; 258(2 Part 2): H414-H418. (Pubitemid 20103163)
41. Ohama E, Ikuta F. Involvement of choroid plexus in mitochondrial encephalomyopathy (MELAS). Acta Neuropathologica 1987; 75: 1-7. (Pubitemid 18011880)
42. Ohama E, Ikuta F, Nakamura N. Mitochondrial abnormalities in choroid plexus of Leigh disease. Brain & Dev 1988; 10: 30-35.
43. Spector R, Johanson CE. Choroid plexus failure in the Kearns-Sayre syndrome. Cerebrospinal Fluid Res 2010; 7: 14.
44. Kao L, Kurtz LM, Shao X, Papadopoulos MC, Liu L, Bok D et al. Severe neurologic impairment in mice with targeted disruption of the electrogenic sodium bicarbonate cotransporter NBCe2 (Slc4a5 gene). J Biol Chem 2011; 286: 32563-32574.
45. Johanson C, Stopa E, Baird A, Sharma H. Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. J Neural Transm 2011; 118: 115-133.
46. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992; 16: 525-534.
47. Meller R, Babity JM, Grahame-Smith DG. 5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells. Neuromol Med 2002; 1: 197-205. (Pubitemid 37012516)
48. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 1997; 17: 2785-2795. (Pubitemid 27155012)
49. Sapolsky RM, Krey LC, McEwen BS. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 1984; 114: 287-292. (Pubitemid 14221903)
50. Noguchi T, Makino S, Matsumoto R, Nakayama S, Nishiyama M, Terada Y et al. Regulation of glucocorticoid receptor transcription and nuclear translocation during single and repeated immobilization stress. Endocrinology 2010; 151: 4344-4355.
51. Johanson CE, Palm DE, Primiano MJ, McMillan PN, Chan P, Knuckey NW et al. Choroid plexus recovery after transient forebrain ischemia: role of growth factors and other repair mechanisms. Cell Mol Neurobiol 2000; 20: 197-216. (Pubitemid 30091456)
52. Simen BB, Duman CH, Simen AA, Duman RS. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006; 59: 775-785.
53. Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proceedings of the National Academy of Sciences of the United States of America 2008; 105: 751-756. (Pubitemid 351171780)
54. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 2002; 952: 128-134. (Pubitemid 35279495)
55. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-1994.
56. Eriksson C, Nobel S, Winblad B, Schultzberg M. Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides. Cytokine 2000; 12: 423-431. (Pubitemid 30449839)
57. Marques F, Sousa JC, Correia-Neves M, Oliveira P, Sousa N, Palha JA. The choroid plexus response to peripheral inflammatory stimulus. Neuroscience 2007; 144: 424-430. (Pubitemid 44873041)
58. Martinez JM, Garakani A, Yehuda R, Gorman JM. Proinflammatory and 'resiliency' proteins in the CSF of patients with major depression. Depression and Anxiety 2012; 29: 32-38.
59. Engelhardt B, Wolburg-Buchholz K, Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech 2001; 52: 112-129. (Pubitemid 32065034)
60. Fliegauf M, Benzing T, Omran H. When cilia go bad: cilia defects and ciliopathies. Nat Rev 2007; 8: 880-893. (Pubitemid 47622564)
61. Narita K, Kawate T, Kakinuma N, Takeda S. Multiple primary cilia modulate the fluid transcytosis in choroid plexus epithelium. Traffic (Copenhagen, Denmark) 2010; 11: 287-301.
62. Badano JL, Mitsuma N, Beales PL, Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Ann Rev Genomics Hum Genet 2006; 7: 125-148. (Pubitemid 44627925)
63. Hildebrandt F, Benzing T, Katsanis N. Ciliopathies. New Engl J Med 2011; 364: 1533-1543.
64. Neugebauer JM, Amack JD, Peterson AG, Bisgrove BW, Yost HJ. FGF signalling during embryo development regulates cilia length in diverse epithelia. Nature 2009; 458: 651-654.
65. Crouthamel MH, Kelly EJ, Ho RJ. Development and characterization of transgenic mouse models for conditional gene knockout in the blood-brain and blood-CSF barriers. Transgenic Res 2011; 21: 113-130.
66. Gonzalez AM, Leadbeater WE, Burg M, Sims K, Terasaki T, Johanson CE et al. Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system. BMC Neurosci 2011; 12: 4.
67. Regev L, Ezrielev E, Gershon E, Gil S, Chen A. Genetic approach for intracerebroventricular delivery. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 4424-4429.